
Longboard Pharmaceuticals
A clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases.
Market cap
$2.3b
Enterprise value
$2.1b
Share price
$59.98 LBPH
Authorizing premium user...
A clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases.